These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12517437)

  • 1. A quantitative structure-activity relationship study on some matrix metalloproteinase and collagenase inhibitors.
    Kumar D; Gupta SP
    Bioorg Med Chem; 2003 Feb; 11(3):421-6. PubMed ID: 12517437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
    Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative QSAR study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates.
    Gupta SP; Maheswaran V; Pande V; Kumar D
    J Enzyme Inhib Med Chem; 2003 Feb; 18(1):7-13. PubMed ID: 12751815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative structure-activity relationship study of hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.
    Gupta SP; Kumar D; Kumaran S
    Bioorg Med Chem; 2003 May; 11(9):1975-81. PubMed ID: 12670648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative structure-activity relationship study on Clostridium histolyticum collagenase inhibitors: roles of electrotopological state indices.
    Gupta SP; Kumaran S
    Bioorg Med Chem; 2003 Jul; 11(14):3065-71. PubMed ID: 12818668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.
    Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2667-72. PubMed ID: 12217351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitors. Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylated N-4-nitrobenzyl-beta-alanine hydroxamate moieties.
    Scozzafava A; Ilies MA; Manole G; Supuran CT
    Eur J Pharm Sci; 2000 Jul; 11(1):69-79. PubMed ID: 10913755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties.
    Ilies M; Banciu MD; Scozzafava A; Ilies MA; Caproiu MT; Supuran CT
    Bioorg Med Chem; 2003 May; 11(10):2227-39. PubMed ID: 12713832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties.
    Scozzafava A; Supuran CT
    Bioorg Med Chem; 2000 Mar; 8(3):637-45. PubMed ID: 10732980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 May; 43(9):1858-65. PubMed ID: 10794702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative structure-activity relationship study on matrix metalloproteinase inhibitors: piperidine sulfonamide aryl hydroxamic acid analogs.
    Kumaran S; Gupta SP
    J Enzyme Inhib Med Chem; 2007 Feb; 22(1):23-7. PubMed ID: 17373543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of clostridium histolyticum collagenase.
    Supuran CT; Briganti F; Mincione G; Scozzafava A
    J Enzyme Inhib; 2000; 15(2):111-28. PubMed ID: 10938538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties.
    Santos MA; Marques S; Gil M; Tegoni M; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):233-42. PubMed ID: 14506914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationship studies on matrix metalloproteinase inhibitors: hydroxamic acid analogs.
    Gupta SP; Kumaran S
    Med Chem; 2006 May; 2(3):243-50. PubMed ID: 16948470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative structure-activity relationship study on some novel series of hydroxamic acid analogs acting as matrix metalloproteinase inhibitors.
    Kumaran S; Gupta SP
    Med Chem; 2007 Mar; 3(2):167-73. PubMed ID: 17348854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
    Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
    Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors. Part 7. Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate.
    Supuran CT; Scozzafava A
    Eur J Pharm Sci; 2000 Mar; 10(1):67-76. PubMed ID: 10699384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.
    Campbell DA; Xiao XY; Harris D; Ida S; Mortezaei R; Ngu K; Shi L; Tien D; Wang Y; Navre M; Patel DV; Sharr MA; DiJoseph JF; Killar LM; Leone CL; Levin JI; Skotnicki JS
    Bioorg Med Chem Lett; 1998 May; 8(10):1157-62. PubMed ID: 9871727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.
    Marcq V; Mirand C; Decarme M; Emonard H; Hornebeck W
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2843-6. PubMed ID: 14611841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.